Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone versus 50% dextrose injection for first metatarsophalangeal osteoarthritis
IRCT20210308050637N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methylprednisolone and dextrose in hallux rigidus (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Visual Analog Scale and Manchester-Oxford Foot Questionnaire. Started Mar 2021; status: completed.
02
Drugs
methylprednisolonedextrose
03
Conditions
hallux rigidus
Beyond the preview
Go deeper on IRCT20210308050637N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210308050637N1.